Zonisamide for Parkinson′s Disease Dyskinesia: Research on Parkinson′s disease patients with wearing-off symptoms identifies risk factors for dyskinesia when treated with Zonisamide, supporting its potential application in managing motor complications associated with the disease (Mishima et al., 2023).
Zonisamide Property Calculations: Research provides calculated descriptors for Zonisamide among other compounds, aiding in the development of better pharmacological profiles and enhancing its utility in pharmaceutical research for antiepileptic mechanisms (Liu, Acree, and Abraham, 2022).
Zonisamide Quantification in Therapy: A method using LC-MS/MS for the quantification of Zonisamide from dried sample spots demonstrates advancements in therapeutic drug monitoring, ensuring effective dosing and patient safety in clinical settings (DʼUrso et al., 2019).
